Acute Effects of Maternal Exercise and the Growth Restricted Pregnancy
1 other identifier
observational
40
1 country
1
Brief Summary
Objectives / Specific Aims
- The purpose of this study is to investigate the acute effects of a single bout of moderate intensity maternal exercise on fetal well-being in a pregnancy affected by fetal growth restriction. Fetal well-being will be measured by biophysical profile (BPP), non-stress test (NST) and umbilical artery dopplers.
- The hypothesis is that a single bout of maternal exercise will not significantly alter fetal well-being or fetal status.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Nov 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2022
CompletedFirst Submitted
Initial submission to the registry
July 11, 2023
CompletedFirst Posted
Study publicly available on registry
September 15, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2024
CompletedFebruary 3, 2026
September 1, 2023
1.7 years
July 11, 2023
January 30, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Change in umbilical artery dopplers systolic/diastolic ratio from pre to post exercise
Change in physiological assessment of umbilical artery dopplers systolic/diastolic ratio measured using ultrasound
Pre to immediately post acute exercise
Secondary Outcomes (10)
Change in uterine artery dopplers from pre to post exercise
Pre to immediately post acute exercise
Change in fetal middle cerebral arterial (MCA) dopplers pulsatility index from pre to post exercise
Pre to immediately post acute exercise
Biophysical Profile (BPP) pre exercise
Pre exercise (within 1 hour of the start of acute exercise bout)
Time to complete Biophysical Profile (BPP) pre exercise
Pre exercise (within 1 hour of the start of acute exercise bout)
Biophysical Profile (BPP) post exercise
Immediately post acute exercise
- +5 more secondary outcomes
Study Arms (2)
Appropriate Growth
Pregnant individuals with normal estimated fetal weight
Fetal Growth Restricted
Pregnant individuals with fetal growth restriction
Interventions
30 minute bout of moderate intensity physical activity performed on a treadmill
Eligibility Criteria
Pregnant individuals, between 28 weeks 0 days and 36 weeks 6 days gestational age with AGA or FGR.
You may qualify if:
- Age 18-45
- Intrauterine pregnancy with diagnosis of fetal growth restriction (FGR) as defined by total estimated fetal weight \<10%ile for EGA or abdominal circumference \<10%ile for EGA
- Gestational age between 28w0d and 36w6d at time of intervention (based on sure last menstrual period (LMP) confirmed by first or second trimester ultrasound or unsure LMP with first trimester ultrasound)
- Compliant with standard prenatal care
- Age 18-45
- Intrauterine pregnancy with normal estimated fetal growth (EFW \>10%ile and \<90%ile)
- Gestational age between 28w0d and 36w6d at time of intervention with accurate dating (based on sure LMP confirmed by ultrasound prior to 22 weeks or unsure LMP with first trimester ultrasound)
- Compliant with standard prenatal care
You may not qualify if:
- Known contraindication to completion of 30 minutes of moderate intensity exercise
- Fetal umbilical artery with elevated S/D ratio or absent or reversed diastolic flow
- BMI \>40
- Severe maternal anemia (Hb less than 8.0)
- Placenta previa
- nd or 3rd trimester vaginal bleeding
- Preterm premature rupture of membranes
- Cervical insufficiency
- Multi-fetal gestation
- Oligohydramnios
- Hypertensive disorder requiring antihypertensive medication
- Blood pressure \>140/90 on the day of the study visit prior to exercise
- Tobacco use
- Opioid agonist therapy
- Known fetal chromosomal anomaly, structural anomaly or infection
- +18 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Tennessee Graduate School of Medicine
Knoxville, Tennessee, 37920, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 11, 2023
First Posted
September 15, 2023
Study Start
November 1, 2022
Primary Completion
June 30, 2024
Study Completion
June 30, 2024
Last Updated
February 3, 2026
Record last verified: 2023-09